Key Takeaways
- • Crescent Capital has priced Atlas Senior Loan Fund XXVIII (Atlas 28), a collateralised loan obligation totaling $406.9m (£303m), according to Alternative Credit Investor.
- • The deal is Crescent's second new-issue CLO of 2026 and the fourth issued through its CLO Equity Fund II, which held its final close in August 2026.
- • The transaction attracted 20 investors and will invest primarily in US senior secured term loans, alongside selected senior secured corporate bonds.
- • Crescent manages $53bn in assets under management and has issued and managed just under $20bn of CLOs since 1992.
Summary
Crescent Capital has priced its latest collateralised loan obligation (CLO), Atlas Senior Loan Fund XXVIII (Atlas 28), at $406.9m (£303m), according to Alternative Credit Investor. The alternative credit manager's transaction marks its second new-issue CLO of 2026 and the fourth issued through its CLO Equity Fund II, which reached its final close in August.
The deal drew 20 investors and will invest primarily in US senior secured term loans, with selected senior secured corporate bonds also in scope. Nilesh Mandhare, managing director, portfolio manager and head of the CLO issuance business at Crescent Capital, said the firm was grateful for the continued support of longstanding investors and welcomed several new investors to the platform through the transaction.
Mandhare attributed the execution to market conditions, noting that volatility in the leveraged loan market gave the team's experienced group the opportunity to selectively acquire assets at attractive prices. He described the approach as reflecting Crescent's disciplined and patient approach to portfolio construction.
Crescent has $53bn of assets under management and has issued and managed just under $20bn of CLOs since 1992, per the report.
The deal drew 20 investors and will invest primarily in US senior secured term loans, with selected senior secured corporate bonds also in scope. Nilesh Mandhare, managing director, portfolio manager and head of the CLO issuance business at Crescent Capital, said the firm was grateful for the continued support of longstanding investors and welcomed several new investors to the platform through the transaction.
Mandhare attributed the execution to market conditions, noting that volatility in the leveraged loan market gave the team's experienced group the opportunity to selectively acquire assets at attractive prices. He described the approach as reflecting Crescent's disciplined and patient approach to portfolio construction.
Crescent has $53bn of assets under management and has issued and managed just under $20bn of CLOs since 1992, per the report.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.